<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="outbreak of SARS-like illness all over the world. As the" exact="SARS-CoV-2 infection" post="pandemic proceeds, many efforts are being dedicated to the"/>
 <result pre="pathogen leading to the outbreak of SARS-like illness (later named" exact="coronavirus disease 2019" post="[COVID-19]) in China.1 As for now, COVID-19 has become"/>
 <result pre="2 (TMPRSS2).37 Hence, camostat mesylate, a TMPRSS2 inhibitor, can eliminate" exact="SARS-CoV-2 infection" post="in vitro assay. On the other hand, the heptad"/>
 <result pre="involved in a signal-dependent SARS-CoV nucleocapsid protein nucleocytoplasmic trafficking during" exact="SARS-CoV infection" post="and could affect host cell division.76â€&quot;80 Besides, the SARS-CoV"/>
 <result pre="REFERENCES 1.ChenNZhouMDongXQuJGongFHanYet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study.Lancet2020;395:507â€&quot;13.32007143 2.PillaiyarTMeenakshisundaramSManickamMRecent discovery and"/>
 <result pre="case of the index patient who caused tertiary transmission of" exact="coronavirus disease 2019" post="in Korea: the application of lopinavir/ritonavir for the treatment"/>
 <result pre="Singapore.JAMA2020;323:1488â€&quot;94.32125362 28.WangZChenXLuYChenFZhangWClinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatment.Biosci Trends2020;14:64â€&quot;8.32037389 29.CaoBWangYWenDLiuWWangJFanGet"/>
</results>
